BackPrometheus Biosciences Overview

Prometheus Biosciences Research & Development

Research & Development expenses for RXDX.

Quarterly R&D Expenses

$36.42M
↑ 30.39% YoY

As of Mar 31, 2023

Annual R&D Expenses (TTM)

$121.36M
↑ 46.92% YoY

Trailing 12 months ending Mar 31, 2023

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin